Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ira Kraus

Podiatrist Fort Oglethorpe, GA Doctor of Podiatric Medicine

NPI 1588667075 CMS profile 253320

2368 Battlefield Pkwy, Fort Oglethorpe, GA 30742

Open in the dashboard

General payments

$223,189

571 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$106,998

6 holdings reported · through program year 2025

Research they led as principal investigator

$23,620 paid to institutions, not to them · program years 2021–2023

Through program year 2025, Ira Kraus of Fort Oglethorpe, GA is reported in the CMS Open Payments database as having received $223,189 across 571 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $23,620 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $106,998 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $116 1
2024 General $1,546 4
2023 General $12,154 50
2022 General $9,414 20
2021 General $90,630 186
2020 General $19,522 53
2019 General $89,807 257
2024 Ownership $24,708 1
2023 Ownership $16,446 1
2022 Ownership $16,443 1
2021 Ownership $16,469 1
2020 Ownership $16,468 1
2019 Ownership $16,464 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ira Kraus
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Ira Kraus were reported at $116. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Ira Kraus Podiatrist median Middle half National median
2019 $89,807 $196 $72–$601 $163
2020 $19,522 $118 $38–$335 $114
2021 $90,630 $169 $57–$573 $132
2022 $9,414 $220 $74–$782 $149
2023 $12,154 $208 $71–$635 $160
2024 $1,546 $237 $87–$681 $164
2025 $116 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organogenesis Inc. $219,886 547 payments
  2. IQ Med LLC $1,412 3 payments
  3. Collaborative Care Diagnostics, LLC $623 8 payments
  4. Kerecis Limited $580 3 payments
  5. Smith+Nephew, Inc. $255 2 payments
  6. GRT US Holding, Inc. $97 1 payment
  7. Wright Medical Technology, Inc. $95 1 payment
  8. Medline Industries, Inc. $94 1 payment
  9. Averitas Pharma Inc. $58 1 payment
  10. Horizon Therapeutics plc $29 1 payment
  11. Other $62 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $100,002 211 payments
  2. Consulting Fee $69,850 29 payments
  3. Travel and Lodging $33,463 219 payments
  4. Honoraria $12,800 5 payments
  5. Food and Beverage $5,662 104 payments
  6. Gift $1,039 1 payment
  7. Current or prospective ownership or investment interest $373 2 payments
Products named General payments · program years 2019–2025
  1. Apligraf Podiatry $89,434 248 payments
  2. Puraply/Affinity/NuTech $89,434 248 payments
  3. Dermagraft $89,434 248 payments
  4. Puraply Antimicrobial $56,919 150 payments
  5. Affinity $47,016 89 payments
  6. Puraply $24,991 44 payments
  7. Apligraf Wound Care $1,209 10 payments
  8. NuShield $1,200 1 payment
  9. PURAPLY WOUND MATRIX $1,200 1 payment
  10. APLIGRAF Wound Care $1,200 1 payment
  11. Other $5,168 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

571 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record